Hey Jane, a telehealth startup that supports safe, private and affordable abortion care, has raised $6.1M in what they are calling their “Roe Round” from Ulu Ventures, The Helm, Amboy Street Ventures, Portfolia, G9, Social Starts and Yard Ventures. The company announced a $2.2M seed round about a year ago and has raised a total of $9.7M to date.
Led by Kiki Freedman, Gaby Izarra and Dr. Kate Shaw, Hey Jane first launched in 2021 and has since supported 20,000 patients. Co-founder Kiki Freedman shares in a blog post: “We know that the abortion pill will become an increasingly crucial option for millions throughout the US following the Court’s decision. And we’re ready. In the past year, we’ve seen a 3x increase in patient demand, grown our clinical team by 5x, and expanded our footprint from three to eight states.”
She continues: “With our Roe Round of funding, we’ll be able to make an even bigger impact — quickly. We plan on using this latest round to continue growing our all-star team, expand access to even more patients through insurance and enterprise partnerships, launch in new states, and treat other common but stigmatized healthcare needs, such as postpartum depression and anxiety, using our innovative Complete Care approach (which combines emotional support and online community with a strong clinical core). By the end of 2023, Hey Jane will expand select services to all 50 states.”
Nancy Torres, Partner at Ulu Ventures commented: “We are thrilled to support Hey Jane’s vision of becoming the most trusted healthcare company. Hey Jane’s approach of delivering clinical, emotional, and social support through one platform has led to industry-leading customer satisfaction and widespread brand loyalty. The trust Hey Jane earns with patients today could extend into other areas of healthcare that impact women and diverse groups disproportionately, and their complete care approach has the potential to support patients over a lifetime.”